Page last updated: 2024-09-04

olmesartan and alprenolol

olmesartan has been researched along with alprenolol in 2 studies

Compound Research Comparison

Studies
(olmesartan)
Trials
(olmesartan)
Recent Studies (post-2010)
(olmesartan)
Studies
(alprenolol)
Trials
(alprenolol)
Recent Studies (post-2010) (alprenolol)
8411855541,14612159

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)alprenolol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.0031
Beta-1 adrenergic receptorHomo sapiens (human)0.007
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.63
Beta-3 adrenergic receptorHomo sapiens (human)0.0023
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0049
Squalene synthaseRattus norvegicus (Norway rat)4.2

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

2 other study(ies) available for olmesartan and alprenolol

ArticleYear
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

    Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023